| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8563219 | Complementary Therapies in Medicine | 2018 | 8 Pages |
Abstract
This nationwide retrospective cohort study provides evidence supporting CHM as an effective adjunctive therapy to ameliorate the side effects of target therapy and prolong the five-year survival rate of patients with advanced NSCLC.
Keywords
MDRGMPICD-9-CMCHMEGFR-TKIscoronary artery diseaseCOPDChronic obstructive pulmonary diseaseGood Manufacturing PracticeInternational Classification of Disease, Ninth Revision, Clinical ModificationCADconfidence intervalMulti-drug resistanceEpidermal growth factor receptor tyrosine kinase inhibitorshazard ratioChinese herbal medicine
Related Topics
Health Sciences
Medicine and Dentistry
Complementary and Alternative Medicine
Authors
Chen-Yu Wang, Hung-Sen Huang, Yuan-Chih Su, Chih-Yen Tu, Te-Chun Hsia, Sheng-Teng Huang,